Sertraline-induced agranulocytosis.
Trescoli-Serrano
C
C
Smith
N K
NK
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D000928:Antidepressive Agents / Q000009:adverse effects*; D016470:Bacteremia / Q000150:complications; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D020280:Sertraline; D012772:Shock, Septic / Q000150:complications
D000928:Antidepressive Agents; D016179:Granulocyte Colony-Stimulating Factor; D015057:1-Naphthylamine; D020280:Sertraline